"Designing Growth Strategies is in our DNA"

Multiple Sclerosis Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Immunomodulators, Immunosuppressants, Interferons, and Others), By Route of Administration (Oral and Injection {Intramuscular, Subcutaneous, and Intravenous}), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2023-2030

Region : Global | Format: PDF | Report ID: FBI100386

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Request Sample PDF

Refresh Button
Booklet
  • Aug, 2023
  • 2022
  • 2019-2021
  • 160

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $6850






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X